Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 15/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 13/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 11/20 | 0.50 |
| ▸ | CTSS | P25774 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2610209 | 0.90 | CTSS (0.52) | CHRM1CHRM2CHRM4CTSSMAOB | |
| Hydrochloric Acid SCHEMBL2115298 | 0.89 | CTSS (0.51) | CHRM1CHRM2CHRM4CTSSMAOB | |
| SCHEMBL2610207 | 0.88 | CHRM1 (0.53) | CHRM1CHRM2CHRM4CTSS | |
| SCHEMBL2610210 | 0.88 | CTSS (0.49) | CHRM1CHRM2CHRM4CTSSMAOB | |
| Hydrochloric Acid SCHEMBL2113656 | 0.87 | CTSS (0.48) | CHRM1CHRM2CHRM4CTSSMAOB | |
| SCHEMBL2113051 | 0.86 | CHRM1 (0.49) | CHRM1CHRM2CHRM4CTSSNAMPT | |
| SCHEMBL2710639 | 0.83 | CHRM1 (0.45) | CHRM1CHRM2CHRM4CTSSNAMPT | |
| SCHEMBL2113182 | 0.83 | CTSS (0.65) | CHRM1CHRM2CHRM4CTSSNAMPT | |
| SCHEMBL2115295 | 0.82 | CTSS (0.55) | CTSSMAOB | |
| SCHEMBL2732555 | 0.82 | CTSS (0.55) | CTSSMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2630141-A1 | CATHEPSIN S INHIBITOR COMPOUNDS | Eli Lilly and Company (US) | 2013-08-28 | — | — | EP | disclosed |
| WO-2012054315-A1 | CATHEPSIN S INHIBITOR COMPOUNDS | ELI LILLY AND COMPANY (US) | 2012-04-26 | — | — | WO | disclosed |